These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7736447)

  • 1. Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition.
    Esteban Bertolesi G; Lauría de Cidre L; Sacerdote de Lustig E; Eiján AM
    Cancer Lett; 1995 Apr; 90(2):123-31. PubMed ID: 7736447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins.
    Bertolesi GE; Lauría de Cidre L; Eiján AM
    Tumour Biol; 1994; 15(5):275-83. PubMed ID: 7991988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin increases the adhesion of murine mammary adenocarcinoma cells (LM3). Correlation with the presence of heparin receptors on cell surface.
    Bertolesi G; Eijan AM; Calvo JC; Lauria de Cidre L
    J Biol Regul Homeost Agents; 2005; 19(1-2):33-40. PubMed ID: 16178272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.
    Guerra FK; Eijan AM; Puricelli L; Alonso DF; Bal de Kier Joffé E; Kornblihgtt AR; Charreau EH; Elizalde PV
    Int J Cancer; 1996 Mar; 65(6):812-20. PubMed ID: 8631597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ability of different chemically modified heparins to potentiate the biological activity of heparin-binding growth factor 1: lack of correlation with growth factor binding.
    Belford DA; Hendry IA; Parish CR
    Biochemistry; 1992 Jul; 31(28):6498-503. PubMed ID: 1378755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of [3H]heparin to human carcinoma SW-13 and other mammalian cells.
    Halper J
    Exp Cell Res; 1990 Apr; 187(2):324-7. PubMed ID: 2156720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and growth-inhibitory effect of heparin and oligo-heparin (2kDa) in Balb/c 3T3 cells: lack of effect on PDGF- or serum-induced inositol lipid turnover.
    Cavari S; Fiorelli G; Vannucchi S
    Br J Pharmacol; 1994 Sep; 113(1):254-60. PubMed ID: 7812618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the profibrinolytic activity of heparin: effects on the activation of plasminogen mediated by urokinase.
    Bertolesi GE; Farías EF; Alonso DF; Bal de Kier Joffé E; Lauría de Cidre S; Eiján AM
    Blood Coagul Fibrinolysis; 1997 Oct; 8(7):403-10. PubMed ID: 9391721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heparin on proliferation and signalling in BC3H-1 muscle cells. Evidence for specific binding sites.
    Vannucchi S; Pasquali F; Fiorelli G; Bianchini P; Ruggiero M
    FEBS Lett; 1990 Apr; 263(1):137-41. PubMed ID: 2158901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
    Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of prostaglandin E2 binding in murine mammary tumor cells differing in metastatic potential.
    Fulton AM; Hanchin CM; Butler WB
    Invasion Metastasis; 1988; 8(1):17-30. PubMed ID: 3422634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of the ability of follicular fluid glycosaminoglycans and chemically desulfated heparin to compete for heparin-binding sites on granulosa cells.
    Bellin ME; Wentworth BC; Ax RL
    Biol Reprod; 1987 Sep; 37(2):293-300. PubMed ID: 2823919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
    Ryan PD; Hilf R
    Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of androgen-induced autocrine heparin-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells.
    Nonomura N; Lu J; Tanaka A; Yamanishi H; Sato B; Sonoda T; Matsumoto K
    Cancer Res; 1990 Apr; 50(8):2316-21. PubMed ID: 2156616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified adhesion behavior after in vitro passage of two related murine mammary adenocarcinomas with different metastasizing ability.
    Bal de Kier Joffé E; Puricelli L; de Lustig ES
    Invasion Metastasis; 1986; 6(5):302-12. PubMed ID: 3781787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.
    Coltrini D; Rusnati M; Zoppetti G; Oreste P; Grazioli G; Naggi A; Presta M
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):583-90. PubMed ID: 7980421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.
    Urtreger AJ; Werbajh SE; Verrecchia F; Mauviel A; Puricelli LI; Kornblihtt AR; Bal de Kier Joffé ED
    Oncol Rep; 2006 Dec; 16(6):1403-10. PubMed ID: 17089068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
    Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
    J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
    Irimura T; Nakajima M; Nicolson GL
    Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.